BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett. 1995;96:267-275. [PMID: 7585467 DOI: 10.1016/0304-3835(95)03930-u] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Abdulla MH, Valli-Mohammed MA, Al-Khayal K, Al Shkieh A, Zubaidi A, Ahmad R, Al-Saleh K, Al-Obeed O, McKerrow J. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages. Oncol Rep 2017;37:3175-80. [PMID: 28440429 DOI: 10.3892/or.2017.5576] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
2 Senthil Kumar P, Anandan S, Subramanian N. Cathepsin D Degradable Dendrimer-MPEG-Histone 3-Enrofloxacin Conjugate Nanovehicle for Target Specific Bovine Mastitis Therapy. Int J Pept Res Ther 2019;25:1451-8. [DOI: 10.1007/s10989-018-9790-x] [Reference Citation Analysis]
3 Soond SM, Savvateeva LV, Makarov VA, Gorokhovets NV, Townsend PA, Zamyatnin AA Jr. Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis. Cancers (Basel) 2020;12:E3476. [PMID: 33266503 DOI: 10.3390/cancers12113476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Hung KE, Faca V, Song K, Sarracino DA, Richard LG, Krastins B, Forrester S, Porter A, Kunin A, Mahmood U. Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis. Cancer Prev Res (Phila). 2009;2:224-233. [PMID: 19240248 DOI: 10.1158/1940-6207.capr-08-0153] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
5 Szwed R, Grzebieniak Z, Saleh Y, Ekonjo GB, Siewinski M. Cysteine peptidase and its inhibitor activity levels and vitamin E concentration in normal human serum and colorectal carcinomas. World J Gastroenterol 2005; 11(6): 850-853 [PMID: 15682479 DOI: 10.3748/wjg.v11.i6.850] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Zhang J, Jin Y, Xu S, Zheng J, Zhang QI, Wang Y, Chen J, Huang Y, He X, Zhao Z. AGR2 is associated with gastric cancer progression and poor survival. Oncol Lett 2016;11:2075-83. [PMID: 26998125 DOI: 10.3892/ol.2016.4160] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
7 Lin WW, Lu YC, Chuang CH, Cheng TL. Ab locks for improving the selectivity and safety of antibody drugs. J Biomed Sci 2020;27:76. [PMID: 32586313 DOI: 10.1186/s12929-020-00652-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Menzel K, Hausmann M, Obermeier F, Schreiter K, Dunger N, Bataille F, Falk W, Scholmerich J, Herfarth H, Rogler G. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol 2006;146:169-80. [PMID: 16968411 DOI: 10.1111/j.1365-2249.2006.03188.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
9 Bian B, Mongrain S, Cagnol S, Langlois MJ, Boulanger J, Bernatchez G, Carrier JC, Boudreau F, Rivard N. Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis. Mol Carcinog 2016;55:671-87. [PMID: 25808857 DOI: 10.1002/mc.22312] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
10 Rangiah K, Tippornwong M, Sangar V, Austin D, Tétreault MP, Rustgi AK, Blair IA, Yu KH. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer. J Proteome Res 2009;8:5153-64. [PMID: 19769411 DOI: 10.1021/pr900518v] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
11 Lwin TM, Turner MA, Amirfakhri S, Nishino H, Hoffman RM, Bouvet M. Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible. Cells 2022;11:249. [DOI: 10.3390/cells11020249] [Reference Citation Analysis]
12 Kirana C, Shi H, Laing E, Hood K, Miller R, Bethwaite P, Keating J, Jordan TW, Hayes M, Stubbs R. Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays. Int J Proteomics. 2012;2012:245819. [PMID: 22919486 DOI: 10.1155/2012/245819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
13 Ehrsam D, Porta F, Hussner J, Seibert I, Meyer Zu Schwabedissen HE. PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism. Materials (Basel) 2019;12:E2836. [PMID: 31484396 DOI: 10.3390/ma12172836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Gass S, Harris J, Ormandy C, Brisken C. Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function. J Mammary Gland Biol Neoplasia 2003;8:269-85. [PMID: 14973373 DOI: 10.1023/b:jomg.0000010029.85796.63] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
15 Oh SS, Park S, Lee KW, Madhi H, Park SG, Lee HG, Cho YY, Yoo J, Dong Kim K. Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation. Cell Death Dis 2017;8:e2729. [PMID: 28383558 DOI: 10.1038/cddis.2017.153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
16 Lee SJ, Jeong YI, Park HK, Kang DH, Oh JS, Lee SG, Lee HC. Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery. Int J Nanomedicine 2015;10:5489-503. [PMID: 26357473 DOI: 10.2147/IJN.S87145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
17 Sudhan DR, Siemann DW. Cathepsin L targeting in cancer treatment. Pharmacol Ther 2015;155:105-16. [PMID: 26299995 DOI: 10.1016/j.pharmthera.2015.08.007] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 10.4] [Reference Citation Analysis]
18 Nadal C, Maurel J, Gascon P. Is there a genetic signature for liver metastasis in colorectal cancer? World J Gastroenterol 2007; 13(44): 5832-5844 [PMID: 17990349 DOI: 10.3748/wjg.v13.i44.5832] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
19 Chan AT, Baba Y, Shima K, Nosho K, Chung DC, Hung KE, Mahmood U, Madden K, Poss K, Ranieri A. Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia. Cancer Epidemiol Biomarkers Prev. 2010;19:2777-2785. [PMID: 20833970 DOI: 10.1158/1055-9965.EPI-10-0529] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
20 Herszényi L, Farinati F, Cardin R, István G, Molnár LD, Hritz I, De Paoli M, Plebani M, Tulassay Z. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer. 2008;8:194. [PMID: 18616803 DOI: 10.1186/1471-2407-8-194] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
21 Ikeguchi M, Sakatani T, Ueta T, Fukuda K, Oka S, Hisamitsu K, Yamaguchi K, Tsujitani S, Kaibara N. Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma. J Clin Pathol 2002;55:121-6. [PMID: 11865007 DOI: 10.1136/jcp.55.2.121] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
22 Sebzda T, Gnus J, Dziadkowiec B, Latka M, Gburek J. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma. World J Gastroenterol 2021; 27(39): 6673-6688 [PMID: 34754160 DOI: 10.3748/wjg.v27.i39.6673] [Reference Citation Analysis]
23 Olson OC, Joyce JA. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer 2015;15:712-29. [PMID: 26597527 DOI: 10.1038/nrc4027] [Cited by in Crossref: 297] [Cited by in F6Publishing: 282] [Article Influence: 49.5] [Reference Citation Analysis]
24 Herszényi L, Barabás L, Hritz I, István G, Tulassay Z. Impact of proteolytic enzymes in colorectal cancer development and progression. World J Gastroenterol 2014; 20(37): 13246-13257 [PMID: 25309062 DOI: 10.3748/wjg.v20.i37.13246] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]